University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
NCT Number: NCT03346772
Better understanding of the immune responses to influenza vaccination is needed in order to understand situations of poor vaccine response. Adults will receive influenza vaccination and then have peripheral blood drawn at pre-defined intervals in order to study the lymphocyte responses.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 4
Philadelphia, Pennsylvania, 19104, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Adults will receive one intramuscular dose of seasonal quadrivalent inactivated influenza vaccine, as indicated for standard of care.
Time frame: 21-42 days
University of Pennsylvania
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06850051
Healthy Volunteers, Human Metapneumovirus Vaccination
Blacktown, New South Wales, Australia
View Trial DetailsNCT07231016
Communicable Diseases, Disease Attributes
Taipei, Taiwan
View Trial DetailsNCT05479370
Infections, Influenza Vaccination
Singapore
View Trial DetailsNCT05785078
Infections, Influenza Vaccination
Rome, RM, Italy
View Trial Details